<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=1575506949302542&amp;ev=PageView&amp;noscript=1">
News

Fobi Announces Launch of New Access & Healthcare Solutions with Draganfly & Empower Clinics on March 1st with Joint Webinar

Joint solutions leverage the new PassPro Wallet pass platform to deliver more interoperable and automated access and healthcare solutions


VANCOUVER, B.C. February 23, 2022, Fobi AI Inc. (TSXV: FOBI) (OTCQB: FOBIF) (the “Company” or “FOBI”), a leader in providing real-time data analytics through artificial intelligence to drive operational efficiencies and profitability, today announced their new Access & Healthcare Solutions, which will be launched jointly together on a webinar on March 1st, 2022 with key partners Draganfly (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) and Empower Clinics Inc. (CBDT: CSE) (8EC:Frankfurt) (EPWCF: OTCQB).

LACK OF INTEROPERABILITY AND AUTOMATION ACROSS INDUSTRIES IS CAUSING ISSUES FOR ORGANIZATIONS AND FOR THE USER EXPERIENCE

Lack of interoperability and automation for access solutions are some of the most important challenges for venues, tourism, in-person events and healthcare. The friction these issues cause across industries and in the community is getting more difficult for organizations, and for the user experience, and there is a growing need for flexible and agile solutions.

 

Fobi digitally transforms organizations to help them solve access, data interoperability and automation problems within the healthcare, tourism, venue management and other industries. The Fobi PassPro platform solves multiple pain points thanks to system integrations with industry leaders like Draganfly and Empower.

 

Fobi, together with partners Draganfly & Empower can now automatically deliver customers’ verified credentials like test results, vital signs, access privileges and more to both a Fobi PassPro Wallet pass for easy customer access, as well as to a back-end portal for improved management by organizations.   

 

Panelists for the webinar will be:

  • Rob Anson, CEO of Fobi
  • Tamer Shafiq, CTO of Fobi
  • Cameron Chell, CEO of Draganfly
  • Steve Mcauley, CEO of Empower Clinics 

Additional details about the joint solutions will be shared in the Webinar to be held March 1st, 2022 at 3PM PST. You can register for this webinar here.

 

This press release is available on the Fobi website, and also on the Verified Forum On AGORACOM For Shareholder Discussion And Management Engagement. 

 

About Draganfly

 

Draganfly Inc. (NASDAQ: DPRO; CSE: DPRO; FSE: 3U8) is the creator of quality, cutting-edge drone solutions, software and AI systems that revolutionize the way organizations can do business and service their stakeholders. Recognized as being at the forefront of technology for over 20 years, Draganfly is an award-winning, industry-leader serving the public safety, agriculture, industrial inspections, security, mapping and surveying markets. Draganfly is a company driven by passion, ingenuity, and the need to provide efficient solutions and first-class services to its customers around the world with the goal of saving time, money, and lives.

 

For more information on Draganfly, please visit us at www.draganfly.com.

For additional investor information visit https://www.thecse.com/en/listings/technology/draganfly-inc, https://www.nasdaq.com/market-activity/stocks/dpro or https://www.boerse-frankfurt.de/aktie/draganfly-inc.

 

Media Contact

Arian Hopkins

Email: media@draganfly.com

 

Company Contact

Email: info@draganfly.com

 

About Empower Clinics Inc.

Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics &amp; Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.

 

ON BEHALF OF THE BOARD OF DIRECTORS:

Steven McAuley

Chief Executive Officer

CONTACTS:

Investors:

Steven McAuley CEO

s.mcauley@empowerclinics.com

604-789-2146

Investors:

Tamara Mason, Business Development & Communications

t.mason@empowerclinics.com

416-671-5617

 

About Fobi

Fobi is a cutting-edge data intelligence company that helps our clients turn real-time data into actionable insights and personalized customer engagement to generate increased profits. Fobi's unique IoT device has the ability to integrate seamlessly into existing infrastructure to enable data connectivity across online and on-premise platforms creating highly scalable solutions for our global clients. Fobi partners with some of the largest companies in the world to deliver best-in-class solutions and operates globally in the retail, telecom, sports & entertainment, casino gaming, and hospitality & tourism industries.

For more information, please contact:

Fobi AI Inc.

 

Fobi Website: www.fobi.ai

Rob Anson, CEO

 

Facebook: @ Fobiinc

T : +1 877-754-5336 Ext. 3

 

Twitter: @ Fobi_inc

E: ir@fobi.ai

 

LinkedIn: @ Fobiinc

 

This news release contains certain statements which constitute forward-looking statements or information, including statements relating to the use of proceeds from the Offering. Such forward-looking statements are subject to numerous risks and uncertainties, some of which are beyond the Company's control, including the impact of general economic and capital markets conditions, stock market volatility and the ability to access sufficient capital from internal and external sources. Although the Company believes that the expectations in its forward-looking statements are reasonable, they are based on factors and assumptions concerning future events which may prove to be inaccurate. Those factors and assumptions are based upon currently available information. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors that could influence actual results or events and cause actual results or events to differ materially from those stated, anticipated or implied in the forward-looking statements. As such, readers are cautioned not to place undue reliance on the forward-looking statements, as no assurance can be provided as to future plans, operations, results, levels of activity or achievements. The forward-looking statements contained in this news release are made as of the date of this news release and, except as required by applicable law, the Company does not undertake any obligation to publicly update or to revise any of the included forward-looking statements, whether as a result of new information, future events or otherwise. The forward-looking statements contained in this document are expressly qualified by this cautionary statement. Trading in the securities of the Company should be considered highly speculative. There can be no assurance that the Company will be able to achieve all or any of its proposed objectives.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accept responsibility for the adequacy or accuracy of this release.

 

 

Similar posts